Aqviko-M5 Tablet
By Aqviko-M
Rx
10 Tablet in a Strip

Composition
Amitriptyline(5mg) + Methylcobalamin(1500mcg)

Manufacturer - Canviko Healthcare Pvt Ltd
Globe Business Park, Unit No.141, Plot No.30, K-B Road, Ambernath, Maharashtra 421501

Expires on or after
June, 2027

liver
When using Aqviko-M5 Tablet, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment, so consulting your doctor is essential. It is advised not to use Aqviko-M5 Tablet in cases of severe liver disease. Prioritize your liver health and seek guidance from your healthcare provider to ensure safe usage of the medication.

kidney
Aqviko-M5 Tablet is believed to be safe for use in patients with kidney disease. Existing data indicates that dosage adjustment may not be necessary. It is advisable to consult your doctor regarding this matter.

alcohol
When taking Aqviko-M5 Tablet, it is advised not to drink alcohol as it is unsafe to do so.

driving
Avoid driving if you experience impaired alertness or side effects from Aqviko-M5 Tablet that may hinder your ability to drive safely.

pregnancy
Aqviko-M5 Tablet may be unsafe during pregnancy. Limited human studies suggest potential harm to the baby. Consult your doctor for a thorough evaluation of benefits and risks before use.

breastfeeding
Caution should be taken while breastfeeding and using Aqviko-M5 Tablet as it may be unsafe. Limited data indicates potential harm to the baby through breastmilk transmission.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | NEURO CNS |
| Action Class | - |
₹109.65
₹129
15% OFF
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024
